Biogen says patient death unlikely linked to new MS drug
(Reuters) - The death of a patient who had taken Biogen Idec Inc's new multiple sclerosis drug, Tecfidera, was unlikely to be linked to the medicine, ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/oOI8R7kQvs8/story01.htm
No comments:
Post a Comment